Global experts speak at first-ever International Congress on Clean Cooling

Scientists at the University of Birmingham are set to receive a major cash boost for pioneering research into cancer. Cancer Research UK is planning to invest nearly £11m over the next five years in ground-breaking work being carried out by the University of Birmingham-based Cancer Research UK Clinical Trials Unit (CRCTU)*. The grant will allow doctors and scientists to continue researching and testing better and kinder treatments for patients. The Birmingham CRCTU gives both adults and children with cancer access to innovative treatments and enables them to benefit from the latest discoveries. It has an expert team of over 200 cancer researchers working across a wide range of cancers, including breast, lung, skin, sarcoma, blood cancers and head and neck cancers as well as a unique team for childhood cancer trials. The Children's Cancer Trials Team is the only one of its kind in the UK, putting Birmingham at the forefront of childhood cancer research. The team coordinates ground-breaking clinical trials across the UK and internationally.